What Infloc 2 % Pomada Treats: Main Uses and Benefits

Infloc 2 % Pomada is commonly used across therapeutic domains, including those relevant to bacterial skin infections. The active substance is used for non-severe, localized primary skin infections. This ointment is commonly used across conditions presenting with acute episodes of primary bacterial skin infection, such as Impetigo (school sores), Folliculitis, and localized boils. It is also applicable in situations where conditions like dermatitis or minor wounds develop a secondary bacterial infection.

The primary benefit involves supportive relief in conditions where bacterial activity is involved. It directly helps address pronounced manifestations like the redness, swelling, and purulent discharge seen in active skin infections. By assisting with symptom clusters that may become intense or disruptive, it offers symptomatic relief that may help patients cope more steadily with difficult episodes, and contributes to improved day-to-day comfort during symptomatic periods. This is generally applied when symptoms interfere with daily comfort.

---

Quick Fact: Relevance for Inflammatory States
Symptom Group: Symptoms related to inflammatory or irritative states.
Context: Commonly used when symptoms interfere with daily comfort.

Infloc 2 % Pomada is a topical antibiotic ointment whose active ingredient is fusidic acid (2%). It is indicated for treating a variety of localized skin infections caused by bacteria sensitive to fusidic acid, primarily Staphylococcus species.

Who Can Use Infloc 2 % Pomada?

This ointment is generally used by patients for the treatment of common bacterial skin infections, including:

• Boils (furuncles)
• Impetigo (a superficial skin infection)
• Pyoderma
• Abscesses
• Folliculitis (inflammation of hair follicles)
• Infected acne and wounds

Who Cannot Use Infloc 2 % Pomada?

This medication is contraindicated and should not be used by individuals with a known hypersensitivity or allergy to fusidic acid, the active substance, or to any of the excipients (inactive ingredients) in the ointment's formulation.

Patients should also consult a healthcare professional before use if the infection involves a large area of skin, is near the eyes, or if there is any doubt regarding the type of infection.

Interaction Scope

The official regulatory profile for Infloc 2 % Pomada is defined by the negligible systemic absorption of the active ingredient, Fusidic Acid, following topical application. This inherent pharmacokinetic characteristic prevents the active substance from reaching the plasma concentrations required to cause systemic drug-drug interactions. Consequently, regulatory documents do not list any specific medicinal product categories or individual medicines that interact with the ointment. The mechanistic basis for this is officially stated as the low systemic exposure.

---

Interaction Classifications (High-Level)

Interactions with systemically administered medicinal products are consistently classified as minimal by official regulatory authorities. This classification is directly tied to the topical route of administration. There are no known or documented interactions with food, alcohol, herbal products, or supplements that require timing separation or dietary restrictions. No formal contraindicated combinations or special population-specific notes regarding interaction severity are listed in the product information for this ointment.

---

Resulting Interaction Structure

Official regulatory statements confirm that no specific drug interaction studies have been performed for the topical formulation. Due to the lack of systemic exposure, no documented exposure-altering effects, such as changes in plasma concentrations (AUC/Cmax), have been identified. This status means no mandatory timing rules are required for co-administration with other medicines, and no interaction-related restrictions are listed.

How Infloc 2 % Pomada Works (Mechanism of Action)

The action of Infloc 2 % Pomada, containing Fusidic Acid, is purely mechanistic and focused on disrupting the core metabolic processes of susceptible bacteria.

Specific Arrest of Bacterial Protein Synthesis

The active ingredient specifically targets the bacterial 70S ribosome and the enzyme Elongation Factor G ( EF-G). Fusidic Acid functions as an inhibitor, binding to the ribosome and physically locking EF-G in place. This binding inhibits the translocation of genetic material ( mRNA) and the growing protein chain, thereby ceasing the manufacturing of all essential bacterial proteins.

Mechanistic Control of Microbial Proliferation

This cessation of protein synthesis inhibits the target bacteria from dividing or multiplying, establishing a state of bacteriostasis (growth arrest). This mechanism achieves the containment of the microbial population, which stabilizes the bacterial load and allows the host's physiological clearance mechanisms to proceed.

Biological Selectivity and Mechanistic Limitations

The drug exhibits high selective toxicity because the human 80S ribosome is structurally distinct. Conversely, the mechanism is biologically limited by bacterial resistance genes (e.g., fusB), which promote active drug displacement, and by membrane barriers in Gram-negative bacteria, which restrict drug access to the ribosomal target.

How to Use Infloc 2 % Pomada

This section describes the standard application and dosing regimen for Infloc 2 % Pomada (Fusidic Acid 2% Ointment). This information focuses solely on the manner and schedule of use and does not cover therapeutic claims or safety information.

---

Administration Guidelines

Feature	Instruction
Route of Administration	The medicine is strictly for cutaneous use (topical application) and is designated as external use only.
Application Regimen	A small amount of the ointment should be applied to the affected area in a thin film.
Frequency	For uncovered skin lesions, the preparation is typically applied three or four times daily. When an occlusive dressing or bandage is used, application frequency may be reduced to, for example, one or two times daily.
Treatment Duration	The typical course of treatment is seven days. Treatment should not normally exceed 14 days to mitigate the potential for bacterial resistance.

---

Use Protocol

Infloc 2 % Pomada is manufactured as an ointment with a 2% concentration of Fusidic Acid. The application procedure is standardized for both adults and the paediatric population (children). Care must be taken to avoid contact with the eyes, especially during application to the face. The overall use protocol is defined by a consistent, short-term course of treatment that limits the total exposure duration. The variability in frequency is the key determinant of use, depending on whether or not a covering is used over the lesion.

Research Evidence / Overview of Studies for Infloc 2 % Pomada

Research examining Infloc 2% Pomada focuses on different clinical situations where the product was studied. This research provides context regarding group patterns observed in the studies, but does not offer individual predictions. The evidence base generally involves studies that explored short-term symptom changes and often looked at episodic symptom patterns related to skin infections.

---

Evidence for Localized Impetigo and Other Infections

The core evidence for localized impetigo largely stems from Randomized Controlled Trials (RCTs) and systematic reviews. These studies monitored endpoints related to lesion change and bacterial presence in affected pediatric and adult populations. Comparative trials monitored measured changes when comparing the ointment to other topical and oral anti-bacterial agents. Findings describe patterns observed in the studies regarding outcomes related to physical discomfort.

For other superficial skin infections, such as secondary infected dermatoses, studies monitored overall clinical response and patient-reported outcomes describing perceived discomfort. Data show patterns observed in the studies regarding the healing time for susceptible infections. These trials often had sample sizes that were modest, and evidence quality varies across the mixed study populations.

---

Research Gaps and Uncertainty

The evidence base primarily reflects short-term data derived from studies that monitored measured changes over defined time intervals. Long-term effects, such as the durability of the initial cure or rates of infection recurrence, are not fully established by the available research. Data for certain groups, including older adults or those with complex chronic conditions, remain insufficient.

Inconsistent results in studies focusing on broader, secondary infections indicate that data are still emerging in these areas. Additionally, geographical variability in bacterial resistance patterns may introduce uncertainty regarding bacteriological outcomes. The research does not determine whether an individual will respond similarly, as findings describe group patterns, not personal outcomes.

Key Studies & References

1. WHO ATC Classification: D06AX01 Other Antibiotics for Topical Use
2. UK National Institute for Health and Care Excellence (NICE) Guidelines: Impetigo - antimicrobial prescribing

Common questions about Infloc 2 % Pomada (FAQ)

Q: What is Infloc 2 % Pomada and what is it used for?

Infloc 2 % Pomada is a topical medication that contains the active ingredient miconazole nitrate at a concentration of 2%.

Miconazole is an antifungal agent that works by interfering with the structure of the fungal cell wall, which inhibits the growth of the fungus.

It is primarily used to treat certain skin and nail infections caused by fungi, such as:

• Athlete's foot (Tinea pedis)
• Jock itch (Tinea cruris)
• Ringworm (Tinea corporis)
• Skin infections caused by Candida (e.g., in the diaper area or skin folds)

---

Q: How should I apply Infloc 2 % Pomada?

Before application, clean and dry the affected area thoroughly. This helps the medicine work better and prevents further spread of the infection.

Apply a thin layer of the pomada to the infected skin and the immediate surrounding area. Gently rub it in until it disappears.

• How often: It is typically applied once or twice a day, or as directed by a healthcare professional.
• Duration: The duration of treatment depends on the infection type and severity. Generally, treatment should continue for up to two to four weeks, even if symptoms improve earlier. Stopping too soon can cause the infection to return.
• Hands: Wash your hands immediately after applying the pomada to avoid spreading the infection to other parts of your body or to other people.

---

Q: Can I use Infloc 2 % Pomada for vaginal yeast infections?

Infloc 2 % Pomada is formulated for external skin use and is used for treating fungal infections like athlete's foot and ringworm.

While the active ingredient, miconazole, is also used in products for vaginal yeast infections, this specific pomada formulation is not intended for internal or vaginal use. You should only use the specific product recommended by your healthcare provider for that area.

---

Q: What should I do if I miss an application?

If you miss an application of Infloc 2 % Pomada, apply it as soon as you remember. However, if it is almost time for your next scheduled application, skip the missed dose and continue with your regular schedule. Do not apply a double dose to make up for a missed one.

Consistency is important for effective treatment. Try to apply the pomada at the same time(s) each day.

How to Store and Dispose of Infloc 2 % Pomada

Storage and disposal instructions for Infloc 2 % Pomada (Fusidic Acid 2% Ointment) are defined by regulatory documents to maintain product quality and safety.

---

Official Storage Requirements

Condition
Do not store above 25 C.
Do not refrigerate or freeze.
Keep the product out of the sight and reach of children.
Store in the original container, tightly closed, protected from light and moisture.
The ointment must be discarded 4 weeks after the tube is first opened.

---

Disposal Requirements

Official instructions state that the medicine should not be disposed of via wastewater or household waste. Unused or expired product must be disposed of in accordance with local requirements. Patients should consult their pharmacist for proper disposal methods.